FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1100-1102 April 20, 1995 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Rex, J. H.

To the Editor: The prospective study by Rex and colleagues (Nov. 17 issue)¹ comparing amphotericin B with fluconazole for the treatment of candidemia concludes that the two treatments are equally effective. This opinion is echoed and endorsed in the accompanying editorial.² Unfortunately, this randomized, controlled study may in some respects provide the right answer to the wrong question. It may be misconstrued as a mandate for the treatment of all patients with candidemia.

Overall, patients with candidemia treated with either amphotericin B or fluconazole do not appear to have fared much better than untreated historical controls.³ I contend that no . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.